Chief Medical OfficerDr. ONeill F. DCruz M.D. is Chief Medical Officer of the Company. Dr. DCruz was most recently Medical Director Neurology at UCB S.A. and previously Professor of Neurology and Pediatrics at University of North CarolinaChapel Hill. He also earned a MBA at the KenanFlagler Business School UNCChapel Hill. In addition to industry experience in clinical development pharmacovigilance regulatory interactions publicprivate partnerships and business development Dr. DCruz has worked in the field of epilepsy for over two decades as a boardcertified neurologist and epileptologist health policy and patient advocate clinical investigator and consultant to leading pharmaceutical companies. Dr. DCruz was an investigator in Cyberonics E05 study the pivotal study used to obtain the company original PMA approval for the VNS Therapy System in 1997 as well as in clinical studies of most of the currentlymarketed secondgeneration antiepileptic drugs.
Executive Since 2014